AllStripes Research

Unlocking new treatments for people affected by rare disease

Headquarters
San Francisco, USA
CEO & Co-Founder
Nancy Yu
Year founded
2017

As a research platform dedicated to rare diseases, AllStripes makes it easy for patients to contribute to new treatment studies from home. It collects and analyses de-identified medical records to help power faster, better drug development for rare conditions.

Rare diseases affect one in 10 people, but the traditional drug development process doesn’t support the unique needs in rare disease. AllStripes is transforming how patients participate in research, and generating real world evidence that can unlock new treatments.
Share on

Find out more about the initiative on